Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan Cohort (NCT07600866)
Validation of a Body-Composition Segmentation Software (Soma) on a Diverse Cohort of Publicly Available CT Scans
๐ฉบ Plain-English Summary (8th-Grade Level)
This study evaluates the standalone performance of Soma, a deep-learning software developed by Nucleo Research, Inc. for the automated segmentation of body-composition tissues (skeletal muscle, subcutaneous adipose tissue, visceral adipose tissue, and intramuscular adipose tissue) on whole-body computed tomography (CT) images. The aim is to confirm that Soma produces segmentations and tissue-area measurements that agree with a multi-rater expert reference standard, on a diverse cohort representative of demographic and clinical variation. A total of 200 CT scans are sampled by stratified design from a curated pool of 2,066 scans aggregated from six publicly available, de-identified imaging datasets (autoPET, AMOS, MSD Pancreas, CT-ORG, ENHANCE.PET, RATIC). Three board-certified radiologists independently annotate the reference standard at the L3 slice. Primary performance is assessed using the Dice similarity coefficient against the multi-rater reference, with predefined thresholds and BCa bootstrap confidence intervals, both in aggregate and within every demographic and clinical subgroup. Secondary endpoints include Bland-Altman analysis of tissue-area agreement, 95th-percentile Hausdorff distance, Pearson correlation of derived indices, and Cohen's kappa for sarcopenia classification using Skeletal Muscle Index (SMI). The study is fully retrospective on de-identified images, involves no patient contact, and has been determined exempt by Salus IRB (Salus Number 26328) under 45 CFR 46.104(d)(4).
Who can join: Review the eligibility criteria below.
Location: Nucleo Research, Inc. โ San Francisco, California
Age range: 18 Years
๐งช Interventions in This Study
- Soma Body-Composition Segmentation Software (DIAGNOSTIC_TEST)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Nucleo Research, Inc. โ San Francisco, California
๐ Contact the Study Coordinator
Phone: (302) 855-3039
Email: info@nucleoresearch.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Sarcopenia
- Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans โ Kansas City, Missouri
- Muscle Impact of Treating Osteoporosis โ Pittsburgh, Pennsylvania
- Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults โ Kingston, Ontario
- Electrical Stimulation of Human Myocytes in Microgravity โ Orlando, Florida
- BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4 โ Chapel Hill, North Carolina
Explore by condition: All Sarcopenia clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.